TickerFacts.

Company research / SMG

Scotts Miracle-Gro Co (SMG)

Build a valuation ↗↓ Download CSV

SEC name SCOTTS MIRACLE-GRO CO · CIK 0000825542 · NYSE · Agricultural Chemicals

  • Sector Manufacturing
  • Incorporated OH
  • Fiscal year ends Sep 30

For the year ended 2025-09-30, Scotts Miracle-Gro Co reported revenue of $3.41B. Revenue fell 3.9% from the prior annual period.

Key ratios (year ended 2025-09-30)

30.6%
Gross margin
10.5%
Operating margin
4.3%
Net margin
-3.9%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-16

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-27 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-06-27		2025-09-302024-09-302023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-30
Revenuen/a$3.41B$3.55B$3.55B$3.92B$4.92B$4.13B$3.16B$2.66B$2.64B$2.51B
Cost of Revenuen/a$2.35B$2.62B$2.71B$2.89B$3.43B$2.77B$2.13B$1.78B$1.67B$1.60B
Gross Profitn/a$1.04B$850.50M$657.30M$872.90M$1.47B$1.35B$1.02B$864.60M$972.60M$900.30M
R&D Expensen/a$34.80M$34.60M$35.70M$45.30M$45.40M$39.70M$39.60M$42.50M$39.90M$36.00M
Operating Incomen/a$358.60M$208.80M-$174.40M-$434.00M$723.00M$585.20M$409.60M$198.90M$433.40M$447.60M
Depreciation & Amortizationn/an/a$80.60M$92.50M$105.20M$93.80M$94.70M$89.30M$83.40M$73.80M$62.30M
EBITDAn/an/a$289.40M-$81.90M-$328.80M$816.80M$679.90M$498.90M$282.30M$507.20M$509.90M
Net Income$73.90M$145.20M-$34.90M-$380.10M-$437.50M$512.50M$387.40M$460.70M$63.70M$218.30M$315.30M
EPS (Diluted)n/a$2.47-$0.61-$6.79-$7.88$8.96$6.81$8.18$1.12$3.63$5.09
Total Assets$3.17B$2.74B$2.87B$3.41B$4.30B$4.80B$3.38B$3.03B$3.05B$2.75B$2.76B
Total Liabilities$3.38B$3.10B$3.26B$3.68B$4.15B$3.79B$2.68B$2.31B$2.69B$2.09B$2.02B
Long-Term Debtn/a$2.11B$2.23B$2.61B$2.96B$2.28B$1.50B$1.63B$2.03B$1.41B$1.22B
Shareholders' Equity-$208.70M-$357.50M-$390.60M-$267.30M$147.70M$1.01B$702.90M$723.20M$359.60M$661.70M$734.30M
Cash & Equivalents$27.70M$36.60M$71.60M$31.90M$86.80M$244.10M$16.60M$18.80M$33.90M$120.50M$28.60M
Operating Cash Flow$369.30M$371.30M$667.50M$531.00M-$129.00M$271.50M$558.00M$226.80M$342.50M$363.20M$244.00M
Capital Expenditures$106.00M$97.40M$84.00M$92.80M$113.50M$106.90M$62.70M$42.40M$68.20M$69.60M$58.30M
Free Cash Flow$263.30M$273.90M$583.50M$438.20M-$242.50M$164.60M$495.30M$184.40M$274.30M$293.60M$185.70M
Share Repurchases$12.10M$18.40M$5.10M$9.30M$257.90M$129.30M$53.20M$3.10M$327.70M$255.20M$137.40M
Dividends Paid$154.40M$154.30M$151.30M$149.10M$166.20M$143.00M$411.20M$124.50M$120.00M$120.30M$116.60M
Shares Outstanding58.20M57.80M57.10M56.50M55.50M55.60Mn/a55.80M55.30M58.10M60.30M
Dividends Per Sharen/a$2.64$2.64$2.64$2.64$2.52$7.36$2.23$2.14$2.03$1.91
Weighted Average Diluted Sharesn/a58.70M56.80M56.00M55.50M57.20M56.90M56.30M57.10M60.20M62.00M
EPS (Basic)n/a$2.52-$0.61-$6.79-$7.88$9.20$6.96$8.30$1.13$3.68$5.16

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView